ISSN 2146-2372


» Home
» About the Journal
» Editorial Board
» Advisory Board
» Information for Authors
» Ethical Standards and
Procedures
» Journal Archive
» Contact Information
» Publication Policies
» Writing Guide




Topical 0.05% cyclosporin A therapy in children with severe vernal keratoconjunctivitis [Behcet Uz Cocuk Hast Derg]
Behcet Uz Cocuk Hast Derg. 2013; 3(1): 33-37 | DOI: 10.5222/buchd.2013.033  

Topical 0.05% cyclosporin A therapy in children with severe vernal keratoconjunctivitis

Emine Şeker Ün, Şenay Aşık Nacaroğlu
Tepecik Teaching And Research Hospital

OBJECTIVE: To investigate the effectiveness of 0.05% cyclosporin A therapy in children with severe vernal keratoconjunctivitis
METHODS: Between 2010 and 2012, 19 patients with a diagnosis of vernal keratoconjunctivitis were involved into the study. The diagnosis of vernal conjunctivitis was made according to the presence of typical clinical symptoms. The symptoms and signs determined in the patients were seperately scored. For each patient, topical cyclosporine treatment was initiated, and at the 3. and 6. months of the therapy, scoring of the symptoms and signs were performed again.
RESULTS: The mean age of the participating patients (12 male, 7 female) was 10.1 ± 1.7. The scores of the symptoms showed significant improvement during the controls performed at the 3. and 6. months of the treatment. Despite the scores were not significantly improved at the 3. month of the treatment; significant improvements were observed during the controls at the 6.month of the treatment. No adverse effects which causes the end of treatment were observed.
CONCLUSION: Topical 0.05% cyclosporine A treatment was proved to cause significant improvement in clinical signs and symptoms in severe patients with active vernal keratoconjunctivitis. The need for steroids was found to be significantly reduced in these cases. The drug is well tolerated locally.

Keywords: vernal keratoconjunctivitis, cyclosporine A, prognosis


Ciddi vernal keratokonjonktivitli çocuklarda topikal %0,05 siklosporin A tedavisi

Emine Şeker Ün, Şenay Aşık Nacaroğlu
Tepecik Eğitim Araştırma Hastanesi

AMAÇ: Ciddi vernal keratokonjonktivitli çocuklarda %0,05 siklosporin A tedavisinin etkinliğini araştırmak
YÖNTEMLER: : 2010-2012 tarihleri arasında kliniğimizde vernal keratokonjonktivit tanısı alan 19 hasta çalışmaya dahil edildi. Vernal keratokonjonktivitli olguların tanısı tipik klinik bulgulann varlığına göre konuldu. Tüm hastaların semptom ve bulguları skorlandı. Hastalara topical siklosporin tedavisi başlandı. 3. ve 6. ayda tekrar semptom ve bulgu skorlamaları yapıldı.
BULGULAR: Hastaların yaş ortalaması 10.1±1.7 idi. Olguların 12’si erkek, 7’si kadındı. Hastaların semptom skorlarında hem 3. ay hemde 6. ay kontrollerinde belirgin iyileşme saptandı. Hastaların bulgu skorlarında 3. ay kontrollerinde iyileşme belirgin değil iken, 6. ay kontrollerinde belirgin iyileşme ortaya çıkmıştır. Hastaların hiçbirinde tedaviyi kesmeyi gerektiren yan etki ortaya çıkmamıştır.
SONUÇ: Ciddi aktif vernal keratokonjonktivitli hastalarda topikal %0.05 siklosporin A tedavisi klinik semptom ve bulgularda anlamlı düzelme sağlamıştır. Olgularda steroid gereksinimi belirgin olarak azalmıştır. İlaç lokal olarak iyi tolere edilmektedir.

Anahtar Kelimeler: vernal keratokonjonktivit, siklosporin A, prognoz


Emine Şeker Ün, Şenay Aşık Nacaroğlu. Topical 0.05% cyclosporin A therapy in children with severe vernal keratoconjunctivitis. Behcet Uz Cocuk Hast Derg. 2013; 3(1): 33-37

Corresponding Author: Emine Şeker Ün, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar
 (37 accesses)
 (1877 downloaded)






Journal of Dr. Behcet Uz Children's Hospital is indexed by the Web of Science-Emerging Sources Citation Index, EBSCO Academic Search Database, Google Scholar, Microsoft Academic Search, Ulakbim TR Dizin, Türk Medline and the Turkish Citation Index.

LookUs & OnlineMakale

© 2021 Dr Behçet UZ S.B.Ü. Dr.Behçet Uz Children’s Education and Research Hospital